Have you or a loved one used Depo-Provera and been diagnosed with a brain tumor? Lawsuits against Pfizer are surging, claiming the company hid serious risks tied to this birth control shot. Discover the facts about Depo-Provera, its link to cancer, the latest news, and how direct2attorney can help you seek compensation.
What Is Depo-Provera?
Depo-Provera is a widely used injectable birth control developed by Upjohn (now Pfizer). Approved by the FDA in 1992, it delivers medroxyprogesterone acetate every three months to prevent pregnancy by stopping ovulation and altering cervical mucus. Since its introduction, millions of women have chosen it for its convenience. However, early concerns about side effects like bone density loss and cancer risks sparked debates, with the FDA initially rejecting approval in the 1970s due to safety concerns. Despite its popularity, recent evidence suggests serious health risks were not adequately disclosed.
At Direct2Attorney, we believe in your right to justice.
Our legal specialists will review your case thoroughly to identify your options.
We will assess your eligibility and assist you in filing your case, ensuring you feel supported throughout the process.
Depo-Provera and Brain Tumor Risks
A 2024 British Medical Journal study revealed a shocking link: women using Depo-Provera for over a year face a five-to-six-fold increased risk of intracranial meningiomas, a type of brain tumor. Though often non-cancerous, meningiomas can cause debilitating symptoms like seizures, vision loss, and memory issues, often requiring invasive surgery. Lawsuits allege Pfizer knew or should have known about these risks but failed to warn users. Earlier animal studies from the 1960s also hinted at risks of breast and endometrial cancers, fueling claims of negligence and inadequate safety testing.
If you’ve experienced health issues due to Depo-Provera, we are here to help you secure the compensation you deserve. Contact Us
Latest Developments in Depo-Provera Lawsuits
As of April 2025, the Depo-Provera litigation is heating up. An MDL in Florida’s Northern District, led by Judge M. Casey Rodgers, consolidates 27 lawsuits, with thousands more expected. Five bellwether cases are set for trials, with key deadlines in July and August 2025. Recent filings in Nevada, Missouri, and California highlight devastating cases of inoperable tumors. A Pennsylvania class action seeks medical monitoring for at-risk women. Law firms, including direct2attorney, are urging affected women to act fast, as statutes of limitations vary by state.
Lawsuits claim Pfizer failed to warn about the risk of brain tumors, like meningiomas, linked to Depo-Provera, causing severe health issues.
Women diagnosed with brain tumors (e.g., meningiomas) after using Depo-Provera, and their families, may qualify with proof of use and diagnosis.
Risks include brain tumors, bone density loss, blood clots, and possible increased risks of breast or cervical cancer with long-term use.
You may seek damages for medical costs, pain and suffering, lost wages, and other losses tied to brain tumor diagnosis and treatment
Deadlines vary by state, typically one to several years from diagnosis or learning of the tumor link. An attorney can clarify your timeline.
Lawsuits are consolidated in a Florida MDL, with trials planned and new cases accepted. The litigation is expected to expand rapidly.
Contact direct2attorney’s experienced mass tort lawyers for a free consultation to evaluate your claim and guide you through the process.
